tetradecanoylphorbol acetate has been researched along with Parkinson Disease, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbartabar Touri, M; Delaviz, H; Ghavamzadeh, M; Jafari Barmak, M; Parishani, M; Sadeghi, H; Zarezade, V | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Pramipexole reduces inflammation in the experimental animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Carrageenan; Disease Models, Animal; Inflammation; Male; Mice; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2017 |